1. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States;Szmuness, W.; Stevens, C.E.; Harley, E.J.;N Engi J Med,1980
2. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection;Szmuness, W.; Stevens, C.E.; Harley, E.J.,1982
3. Human hepatitis B vaccine from recombinant yeast;McAleer, W.J.; Buynak, E.B.; Maigetter, R.Z.; Wampler, D.E.; Miller, W.J.; Hilleman, M.R.;Nature,1984
4. Quality and safety of human hepatitis B vacqine;Hilleman, M.R.; McAleer, W.J.; Buynak, E.B.; McLean, A.A.;Dev Biol Stand,1983
5. Hepatitis B vaccine: immune responses in haemodialysis patients;Stevens, C.E.; Szmuness, W.; Al, Goodman; Weseley, S.A.; Fortino, M.;Lancet,1980